Vanita Aroda is the Director of Diabetes Clinical Research at the Brigham and Women’s Hospital in Boston, MA, and is an Associate Professor of Medicine at Harvard Medical School. She completed her training in Internal Medicine and in Endocrinology, Diabetes and Metabolism at the University of California San Diego, CA, USA.
Professor Aroda has an interest and published record in diabetes prevention and novel therapeutics in diabetes and weight management. She also has a strong interest in understanding therapeutic interventions in large multicentre clinical trials and their applicability and integration into care. She has years of experience in clinical trial conduct and leadership, has served as an investigator on multiple National Institutes of Health-funded studies, and as the national or international signatory principal investigator for multiple therapeutic clinical trials.
Professor Aroda served on the Professional Practice Committee of the American Diabetes Association (ADA) Standards of Care in Diabetes 2021, 2022 and 2023, and on the international 2022 ADA/EASD consensus group for the management of hyperglycaemia in type 2 diabetes.
Duality of interest:
Professor Vanita Aroda has received research support/grants from Applied Therapeutics, Eli Lilly, Fracytl, Novo Nordisk and Sanofi together with consultancy fees from Applied Therapeutics, Fracytl, Pfizer, Novo Nordisk and Sanofi.
Date: Autumn 2023